COLLEGIUM PHARMACEUTICAL, INC (COLL)

↓ Download CSV

CIK 0001267565 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated VA
  • Fiscal year ends Dec 31

In fiscal 2025, COLLEGIUM PHARMACEUTICAL, INC reported revenue of $780.57M, up 23.6% from the prior year. The company was profitable, with a net margin of 8.1% and a gross margin of 59.3%. It held $1.66B in total assets against $1.36B in total liabilities.

Key ratios (FY2025)

59.3%
Gross margin
23.0%
Operating margin
8.1%
Net margin
20.8%
Return on equity
+23.6%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$780.57M$631.45M$566.77M$463.93M$276.87M$310.02M$296.70M$280.41M$28.48M$1.71M
Cost of Revenue$317.31M$254.10M$240.60M$254.44M$126.25M$130.18M$193.66M$165.68M$2.60M$213.0K
Gross Profit$463.26M$377.34M$326.17M$209.49M$150.62M$179.84M$103.04M$114.74M
Operating Income$179.64M$169.90M$166.96M$33.32M$17.63M$56.23M-$23.75M-$20.68M-$75.45M-$94.08M
Net Income$62.87M$69.19M$48.16M-$25.00M$71.52M$26.75M-$22.72M-$39.13M-$74.86M-$94.18M
EPS (Diluted)$1.98$2.14$1.43$-0.74$2.05$0.78$-0.68$-1.19$-3.88
Total Assets$1.66B$1.66B$1.14B$1.17B$692.08M$643.84M$306.30M$291.25M$135.57M$162.02M
Total Liabilities$1.36B$1.43B$947.88M$979.29M$489.15M$457.81M$218.87M$199.66M$31.49M$27.11M
Shareholders' Equity$301.68M$228.84M$195.43M$194.84M$202.93M$186.03M$87.43M$91.58M$104.08M$134.91M
Cash & Equivalents$231.25M$70.56M$238.95M$173.69M$186.43M$174.12M$170.02M$146.63M$118.70M$153.22M
Operating Cash Flow$329.32M$204.98M$274.75M$124.23M$103.56M$93.94M$27.78M$169.39M-$67.02M-$75.05M
Capital Expenditures$1.74M$1.65M$461.0K$1.62M$1.94M$5.55M$6.44M$5.48M$990.0K$477.0K
Shares Outstanding31.71M31.44M31.87M33.85M33.66M34.61M33.68M33.27M32.77M29.36M